{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T19:02:12Z","timestamp":1780426932165,"version":"3.54.1"},"reference-count":106,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"39","license":[{"start":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T00:00:00Z","timestamp":1758844800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,9,26]]},"abstract":"<jats:p>Proliferative vitreoretinopathy (PVR) is the most common cause of repair failure in rhegmatogenous retinal detachment and a severe complication of posterior segment penetrating injuries. The pathogenesis of PVR is complex, and there is currently no ideal therapeutic drug in clinical practice. Surgical intervention involves the removal of proliferative membranes to relieve traction on the retina, but it carries a certain postoperative recurrence rate. This review provides an overview of the pathogenesis and treatment strategies for PVR.<\/jats:p>","DOI":"10.1097\/md.0000000000044804","type":"journal-article","created":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T16:03:04Z","timestamp":1759248184000},"page":"e44804","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":5,"title":["Pathogenic mechanisms and treatment advances in proliferative vitreoretinopathy: A review"],"prefix":"10.1097","volume":"104","author":[{"given":"Jinhui","family":"Dai","sequence":"first","affiliation":[{"name":"The First Clinical College of Traditional Chinese Medicine, Hunan University of Traditional Chinese Medicine, Changsha, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaorong","family":"Zhou","sequence":"additional","affiliation":[{"name":"The First Clinical College of Traditional Chinese Medicine, Hunan University of Traditional Chinese Medicine, Changsha, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haixia","family":"Bai","sequence":"additional","affiliation":[{"name":"The First Clinical College of Traditional Chinese Medicine, Hunan University of Traditional Chinese Medicine, Changsha, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meiyan","family":"Zeng","sequence":"additional","affiliation":[{"name":"The First Affiliated Hospital of Hunan University of Chinese Medicine, Changsha, China"},{"name":"Hunan Province Traditional Chinese Medicine Prevention and Treatment of Eye, Ear, Nose and Throat Diseases and Visual Function Protection Engineering Technology Research Center, Changsha, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinghua","family":"Peng","sequence":"additional","affiliation":[{"name":"The First Affiliated Hospital of Hunan University of Chinese Medicine, Changsha, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-8493-6482","authenticated-orcid":false,"given":"Quanlong","family":"Wu","sequence":"additional","affiliation":[{"name":"The First Affiliated Hospital of Hunan University of Chinese Medicine, Changsha, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20260602","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.preteyeres.2017.08.001","article-title":"Myofibroblast transdifferentiation: the dark force in ocular wound healing and fibrosis.","volume":"60","author":"Shu","year":"2017","journal-title":"Prog Retin Eye Res"},{"key":"R2-20260602","doi-asserted-by":"crossref","first-page":"112693","DOI":"10.1016\/j.biopha.2022.112693","article-title":"Restorative and pain-relieving effects of fibroin in preclinical models of tendinopathy.","volume":"148","author":"Micheli","year":"2022","journal-title":"Biomed Pharmacother"},{"key":"R3-20260602","doi-asserted-by":"crossref","first-page":"13324","DOI":"10.1111\/jcmm.15951","article-title":"Exosomes mediate an epithelial-mesenchymal transition cascade in retinal pigment epithelial cells: implications for proliferative vitreoretinopathy.","volume":"24","author":"Zhang","year":"2020","journal-title":"J Cell Mol Med"},{"key":"R4-20260602","first-page":"242","article-title":"Effects of the vegetable polyphenols epigallocatechin-3-gallate, luteolin, apigenin, myricetin, quercetin, and cyanidin in primary cultures of human retinal pigment epithelial cells.","volume":"20","author":"Chen","year":"2014","journal-title":"Mol Vis"},{"key":"R5-20260602","doi-asserted-by":"crossref","first-page":"13510","DOI":"10.3390\/ijms241713510","article-title":"Macrophage-myofibroblast transition contributes to myofibroblast formation in proliferative vitreoretinal disorders.","volume":"24","author":"Abu El-Asrar","year":"2023","journal-title":"Int J Mol Sci"},{"key":"R6-20260602","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1002\/jcp.24606","article-title":"Disease pathways in proliferative vitreoretinopathy: an ongoing challenge.","volume":"229","author":"Tosi","year":"2014","journal-title":"J Cell Physiol"},{"key":"R7-20260602","doi-asserted-by":"crossref","first-page":"3940","DOI":"10.1167\/iovs.16-20912","article-title":"Effect of methotrexate on an in vitro patient-derived model of proliferative vitreoretinopathy.","volume":"58","author":"Amarnani","year":"2017","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R8-20260602","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1007\/s00417-016-3582-9","article-title":"The effects of pleiotrophin in proliferative vitreoretinopathy.","volume":"255","author":"Ding","year":"2017","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"R9-20260602","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1167\/tvst.9.3.23","article-title":"Inflammatory and fibrogenic factors in proliferative vitreoretinopathy development.","volume":"9","author":"Chaudhary","year":"2020","journal-title":"Transl Vis Sci Technol"},{"key":"R10-20260602","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1080\/08820538.2021.1890791","article-title":"Molecular targets for proliferative vitreoretinopathy.","volume":"36","author":"Wu","year":"2021","journal-title":"Semin Ophthalmol"},{"key":"R11-20260602","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1038\/s41433-019-0724-4","article-title":"A brief review of the histopathology of proliferative vitreoretinopathy (PVR).","volume":"34","author":"Mudhar","year":"2020","journal-title":"Eye (Lond)"},{"key":"R12-20260602","doi-asserted-by":"crossref","first-page":"2531","DOI":"10.3390\/cells11162531","article-title":"Untangling the extracellular matrix of idiopathic epiretinal membrane: a path winding among structure, interactomics and translational medicine.","volume":"11","author":"Bianchi","year":"2022","journal-title":"Cells"},{"key":"R13-20260602","doi-asserted-by":"crossref","first-page":"501","DOI":"10.3389\/fcell.2020.00501","article-title":"Role of epithelial-mesenchymal transition in retinal pigment epithelium dysfunction.","volume":"8","author":"Zhou","year":"2020","journal-title":"Front Cell Dev Biol"},{"key":"R14-20260602","doi-asserted-by":"crossref","first-page":"886053","DOI":"10.3389\/fcell.2022.886053","article-title":"Lens fibrosis: understanding the dynamics of cell adhesion signaling in lens epithelial-mesenchymal transition.","volume":"10","author":"Taiyab","year":"2022","journal-title":"Front Cell Dev Biol"},{"key":"R15-20260602","doi-asserted-by":"crossref","first-page":"15419","DOI":"10.1038\/s41598-019-51633-8","article-title":"Characterisation of the inflammatory cytokine and growth factor profile in a rabbit model of proliferative vitreoretinopathy.","volume":"9","author":"Wong","year":"2019","journal-title":"Sci Rep"},{"key":"R16-20260602","doi-asserted-by":"crossref","first-page":"4256","DOI":"10.1167\/iovs.10-6892","article-title":"Soluble apoptotic factors and adhesion molecules in rhegmatogenous retinal detachment.","volume":"52","author":"Ricker","year":"2011","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R17-20260602","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.cyto.2014.02.012","article-title":"Comparison of interleukin-6 and matrix metalloproteinase expression in the subretinal fluid and the vitreous during proliferative vitreoretinopathy: correlations with extent, duration of RRD and PVR grade.","volume":"67","author":"Symeonidis","year":"2014","journal-title":"Cytokine"},{"key":"R18-20260602","doi-asserted-by":"crossref","first-page":"505","DOI":"10.3109\/02713681003597248","article-title":"Vitreous levels of VEGF, IL-8, and TNF-alpha in retinal detachment.","volume":"35","author":"Rasier","year":"2010","journal-title":"Curr Eye Res"},{"key":"R19-20260602","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.mam.2017.10.002","article-title":"PDGF-C and PDGF-D in ocular diseases.","volume":"62","author":"Kumar","year":"2018","journal-title":"Mol Aspects Med"},{"key":"R20-20260602","doi-asserted-by":"crossref","first-page":"815937","DOI":"10.1155\/2012\/815937","article-title":"Mechanisms of inflammation in proliferative vitreoretinopathy: from bench to bedside.","volume":"2012","author":"Moysidis","year":"2012","journal-title":"Mediators Inflamm"},{"key":"R21-20260602","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.preteyeres.2013.12.006","article-title":"Is neutralizing vitreal growth factors a viable strategy to prevent proliferative vitreoretinopathy?","volume":"40","author":"Pennock","year":"2014","journal-title":"Prog Retin Eye Res"},{"key":"R22-20260602","doi-asserted-by":"crossref","first-page":"269787","DOI":"10.1155\/2013\/269787","article-title":"Proliferative vitreoretinopathy after eye injuries: an overexpression of growth factors and cytokines leading to a retinal keloid.","volume":"2013","author":"Morescalchi","year":"2013","journal-title":"Mediators Inflamm"},{"key":"R23-20260602","doi-asserted-by":"crossref","first-page":"4509","DOI":"10.3390\/ijms24054509","article-title":"Experimental models to study epithelial-mesenchymal transition in proliferative vitreoretinopathy.","volume":"24","author":"Datlibagi","year":"2023","journal-title":"Int J Mol Sci"},{"key":"R24-20260602","doi-asserted-by":"crossref","first-page":"e10136","DOI":"10.7717\/peerj.10136","article-title":"Polarity and epithelial-mesenchymal transition of retinal pigment epithelial cells in proliferative vitreoretinopathy.","volume":"8","author":"Zou","year":"2020","journal-title":"PeerJ"},{"key":"R25-20260602","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1167\/iovs.61.5.22","article-title":"Increased glial fibrillary acid protein and vimentin in vitreous fluid as a biomarker for proliferative vitreoretinopathy.","volume":"61","author":"Lee","year":"2020","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R26-20260602","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.preteyeres.2009.07.001","article-title":"Cellular signaling and factors involved in M\u00fcller cell gliosis: neuroprotective and detrimental effects.","volume":"28","author":"Bringmann","year":"2009","journal-title":"Prog Retin Eye Res"},{"key":"R27-20260602","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.3109\/02713689209015074","article-title":"Expression of growth factor mRNA in rabbit PVR model systems.","volume":"11","author":"Planck","year":"1992","journal-title":"Curr Eye Res"},{"key":"R28-20260602","first-page":"830","article-title":"Effect of macrophage migration inhibitory factor on inflammatory cytokines and fibrogenic gene expression in human RPE cells.","volume":"20","author":"Qin","year":"2019","journal-title":"Mol Med Rep"},{"key":"R29-20260602","doi-asserted-by":"crossref","first-page":"2784","DOI":"10.2337\/db08-0302","article-title":"Potent inhibition of cicatricial contraction in proliferative vitreoretinal diseases by statins.","volume":"57","author":"Kawahara","year":"2008","journal-title":"Diabetes"},{"key":"R30-20260602","doi-asserted-by":"crossref","first-page":"17504","DOI":"10.1073\/pnas.0804054105","article-title":"Role of TGF-beta in proliferative vitreoretinal diseases and ROCK as a therapeutic target.","volume":"105","author":"Kita","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"key":"R31-20260602","first-page":"477","article-title":"Heterogeneity in localization of isoforms of TGF-beta in human retina, vitreous, and choroid.","volume":"34","author":"Lutty","year":"1993","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R32-20260602","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1097\/IIO.0000000000000258","article-title":"Proliferative vitreoretinopathy: a review.","volume":"59","author":"Idrees","year":"2019","journal-title":"Int Ophthalmol Clin"},{"key":"R33-20260602","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1136\/bjo.2003.040402","article-title":"Silicone oil concentrates fibrogenic growth factors in the retro-oil fluid.","volume":"88","author":"Asaria","year":"2004","journal-title":"Br J Ophthalmol"},{"key":"R34-20260602","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1038\/sj.eye.6700190","article-title":"Novel growth factors involved in the pathogenesis of proliferative vitreoretinopathy.","volume":"16","author":"Hinton","year":"2002","journal-title":"Eye (Lond)"},{"key":"R35-20260602","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1172\/JCI114065","article-title":"Correlation of fibrosis and transforming growth factor-beta type 2 levels in the eye.","volume":"83","author":"Connor","year":"1989","journal-title":"J Clin Invest"},{"key":"R36-20260602","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s00417-013-2377-5","article-title":"Upregulation of TGF-\u03b21 in experimental proliferative vitreoretinopathy is accompanied by epithelial to mesenchymal transition.","volume":"252","author":"Hoerster","year":"2014","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"R37-20260602","doi-asserted-by":"crossref","first-page":"3212","DOI":"10.1096\/fj.201800858RR","article-title":"BMP7 antagonizes proliferative vitreoretinopathy through retinal pigment epithelial fibrosis in vivo and in vitro.","volume":"33","author":"Yao","year":"2019","journal-title":"FASEB J"},{"key":"R38-20260602","doi-asserted-by":"crossref","first-page":"e0122229","DOI":"10.1371\/journal.pone.0122229","article-title":"TGF-\u03b21 induced transdifferentiation of RPE cells is mediated by TAK1.","volume":"10","author":"Dvashi","year":"2015","journal-title":"PLoS One"},{"key":"R39-20260602","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1167\/iovs.12-10931","article-title":"A genetic case-control study confirms the implication of SMAD7 and TNF locus in the development of proliferative vitreoretinopathy.","volume":"54","author":"Rojas","year":"2013","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R40-20260602","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1001\/archopht.125.5.647","article-title":"Effect of Smad7 gene overexpression on transforming growth factor beta-induced retinal pigment fibrosis in a proliferative vitreoretinopathy mouse model.","volume":"125","author":"Saika","year":"2007","journal-title":"Arch Ophthalmol"},{"key":"R41-20260602","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/j.0959-9673.2004.00377.x","article-title":"Smad3 as a mediator of the fibrotic response.","volume":"85","author":"Flanders","year":"2004","journal-title":"Int J Exp Pathol"},{"key":"R42-20260602","doi-asserted-by":"crossref","first-page":"69","DOI":"10.2174\/187153008783928343","article-title":"Epithelial-mesenchymal transition as a therapeutic target for prevention of ocular tissue fibrosis.","volume":"8","author":"Saika","year":"2008","journal-title":"Endocr Metab Immune Disord Drug Targets"},{"key":"R43-20260602","doi-asserted-by":"crossref","first-page":"e20190103","DOI":"10.1084\/jem.20190103","article-title":"Transforming growth factor-\u03b2 in tissue fibrosis.","volume":"217","author":"Frangogiannis","year":"2020","journal-title":"J Exp Med"},{"key":"R44-20260602","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/s00417-013-2531-0","article-title":"Myofibroblast and extracellular matrix origins in proliferative vitreoretinopathy.","volume":"252","author":"Feist","year":"2014","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"R45-20260602","first-page":"225","article-title":"Research progress on signaling pathways related to drug research in proliferative vitreoretinopathy.","volume":"59","author":"Han","year":"2023","journal-title":"Zhonghua Yan Ke Za Zhi"},{"key":"R46-20260602","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.cbi.2018.07.008","article-title":"New insights into TGF-\u03b2\/Smad signaling in tissue fibrosis.","volume":"292","author":"Hu","year":"2018","journal-title":"Chem Biol Interact"},{"key":"R47-20260602","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.18240\/ijo.2019.12.03","article-title":"The role of mechanical stretch and TGF-\u03b22 in epithelial-mesenchymal transition of retinal pigment epithelial cells.","volume":"12","author":"Cao","year":"2019","journal-title":"Int J Ophthalmol"},{"key":"R48-20260602","doi-asserted-by":"crossref","first-page":"991056","DOI":"10.3389\/fphar.2022.991056","article-title":"CD82 attenuates TGF-\u03b21-mediated epithelial-mesenchymal transition by blocking smad-dependent signaling in ARPE-19 cells.","volume":"13","author":"Lee","year":"2022","journal-title":"Front Pharmacol"},{"key":"R49-20260602","doi-asserted-by":"crossref","first-page":"101514","DOI":"10.1016\/j.scr.2019.101514","article-title":"Robust induction of retinal pigment epithelium cells from human induced pluripotent stem cells by inhibiting FGF\/MAPK signaling.","volume":"39","author":"Kuroda","year":"2019","journal-title":"Stem Cell Res"},{"key":"R50-20260602","doi-asserted-by":"crossref","first-page":"3052","DOI":"10.1016\/j.ajpath.2014.07.026","article-title":"Vascular endothelial growth factor acts primarily via platelet-derived growth factor receptor \u03b1 to promote proliferative vitreoretinopathy.","volume":"184","author":"Pennock","year":"2014","journal-title":"Am J Pathol"},{"key":"R51-20260602","doi-asserted-by":"crossref","first-page":"110482","DOI":"10.1016\/j.exer.2025.110482","article-title":"Commonalities between fibrotic and inflammatory mechanisms in proliferative vitreoretinopathy and proliferative diabetic retinopathy.","volume":"258","author":"Sreenivas Bk","year":"2025","journal-title":"Exp Eye Res"},{"key":"R52-20260602","doi-asserted-by":"crossref","first-page":"2242","DOI":"10.3390\/jcm9072242","article-title":"Blockade of platelet-derived growth factor signaling inhibits choroidal neovascularization and subretinal fibrosis in mice.","volume":"9","author":"Liu","year":"2020","journal-title":"J Clin Med"},{"key":"R53-20260602","doi-asserted-by":"crossref","first-page":"108116","DOI":"10.1016\/j.exer.2020.108116","article-title":"PDGFR\u03b2 plays an essential role in patient vitreous-stimulated contraction of retinal pigment epithelial cells from epiretinal membranes.","volume":"197","author":"Yang","year":"2020","journal-title":"Exp Eye Res"},{"key":"R54-20260602","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1186\/s12886-023-03089-8","article-title":"Ligand-independent activation of platelet-derived growth factor receptor \u03b2 promotes vitreous-induced contraction of retinal pigment epithelial cells.","volume":"23","author":"Duan","year":"2023","journal-title":"BMC Ophthalmol"},{"key":"R55-20260602","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1167\/iovs.06-0965","article-title":"A potential role for PDGF-C in experimental and clinical proliferative vitreoretinopathy.","volume":"48","author":"Lei","year":"2007","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R56-20260602","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1038\/35010579","article-title":"PDGF-C is a new protease-activated ligand for the PDGF alpha-receptor.","volume":"2","author":"Li","year":"2000","journal-title":"Nat Cell Biol"},{"key":"R57-20260602","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.ejphar.2018.11.001","article-title":"Crocetin inhibits PDGF-BB-induced proliferation and migration of retinal pigment epithelial cells.","volume":"842","author":"Zhang","year":"2019","journal-title":"Eur J Pharmacol"},{"key":"R58-20260602","doi-asserted-by":"crossref","first-page":"2656","DOI":"10.4049\/jimmunol.139.8.2656","article-title":"Recombinant T cell replacing factor (interleukin 5) acts with antigen to promote the growth and differentiation of single hapten-specific B lymphocytes.","volume":"139","author":"Alderson","year":"1987","journal-title":"J Immunol"},{"key":"R59-20260602","doi-asserted-by":"crossref","first-page":"4234","DOI":"10.1073\/pnas.84.12.4234","article-title":"Interleukin 5, a T-cell-derived B-cell differentiation factor also induces cytotoxic T lymphocytes.","volume":"84","author":"Takatsu","year":"1987","journal-title":"Proc Natl Acad Sci USA"},{"key":"R60-20260602","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.it.2014.12.008","article-title":"Versatile functions for IL-6 in metabolism and cancer.","volume":"36","author":"Mauer","year":"2015","journal-title":"Trends Immunol"},{"key":"R61-20260602","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.yexcr.2014.08.040","article-title":"IL-1\u03b2 induces IL-6 production in retinal M\u00fcller cells predominantly through the activation of p38 MAPK\/NF-\u03baB signaling pathway.","volume":"331","author":"Liu","year":"2015","journal-title":"Exp Cell Res"},{"key":"R62-20260602","doi-asserted-by":"crossref","first-page":"4251","DOI":"10.1167\/iovs.05-0444","article-title":"Multiplex bead immunoassay analysis of aqueous humor reveals distinct cytokine profiles in uveitis.","volume":"46","author":"Curnow","year":"2005","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R63-20260602","first-page":"2591","article-title":"IL-6 antagonizes TGF-beta and abolishes immune privilege in eyes with endotoxin-induced uveitis.","volume":"41","author":"Ohta","year":"2000","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R64-20260602","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1080\/092739490500282","article-title":"Elevated levels of interleukin 6 in the vitreous fluid of patients with pars planitis and posterior uveitis: the Massachusetts Eye & Ear experience and review of previous studies.","volume":"12","author":"Perez","year":"2004","journal-title":"Ocul Immunol Inflamm"},{"key":"R65-20260602","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1136\/bjo.85.4.461","article-title":"Intravitreal invading cells contribute to vitreal cytokine milieu in proliferative vitreoretinopathy.","volume":"85","author":"El-Ghrably","year":"2001","journal-title":"Br J Ophthalmol"},{"key":"R66-20260602","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.exer.2005.05.001","article-title":"Involvement of IL-6 in the paracrine production of VEGF in ocular HSV-1 infection.","volume":"82","author":"Biswas","year":"2006","journal-title":"Exp Eye Res"},{"key":"R67-20260602","first-page":"900","article-title":"Cytokines in vitreous humor: interleukin-6 is elevated in proliferative vitreoretinopathy.","volume":"35","author":"Kauffmann","year":"1994","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"Pt 6","key":"R68-20260602","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1038\/eye.1991.126","article-title":"Cytokines in proliferative vitreoretinopathy.","volume":"5","author":"Limb","year":"1991","journal-title":"Eye (Lond)"},{"key":"R69-20260602","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.jss.2006.05.043","article-title":"Interleukin-1beta and interleukin-6 stimulate matrix metalloproteinase-9 secretion in cultured myenteric glia.","volume":"137","author":"Lin","year":"2007","journal-title":"J Surg Res"},{"key":"R70-20260602","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.cyto.2011.02.001","article-title":"Interleukin-6 and the matrix metalloproteinase response in the vitreous during proliferative vitreoretinopathy.","volume":"54","author":"Symeonidis","year":"2011","journal-title":"Cytokine"},{"key":"R71-20260602","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1016\/j.bbrc.2006.02.100","article-title":"Interleukin-6 triggers human cerebral endothelial cells proliferation and migration: the role for KDR and MMP-9.","volume":"342","author":"Yao","year":"2006","journal-title":"Biochem Biophys Res Commun"},{"key":"R72-20260602","first-page":"417","article-title":"Identification of inflammatory mediators in patients with rhegmatogenous retinal detachment associated with choroidal detachment.","volume":"21","author":"Dai","year":"2015","journal-title":"Mol Vis"},{"key":"R73-20260602","doi-asserted-by":"crossref","first-page":"e580","DOI":"10.1111\/aos.13998","article-title":"Cytokine profiles of phakic and pseudophakic eyes with primary retinal detachment.","volume":"97","author":"Garweg","year":"2019","journal-title":"Acta Ophthalmol"},{"key":"R74-20260602","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.ajo.2017.11.025","article-title":"Personalized proteomics in proliferative vitreoretinopathy implicate hematopoietic cell recruitment and mTOR as a therapeutic target.","volume":"186","author":"Roybal","year":"2018","journal-title":"Am J Ophthalmol"},{"key":"R75-20260602","doi-asserted-by":"crossref","first-page":"e0214674","DOI":"10.1371\/journal.pone.0214674","article-title":"Biomarkers for PVR in rhegmatogenous retinal detachment.","volume":"14","author":"Zandi","year":"2019","journal-title":"PLoS One"},{"key":"R76-20260602","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1159\/000525330","article-title":"Cytokine expression in staphylococcal and streptococcal endophthalmitis.","volume":"7","author":"Soon","year":"2022","journal-title":"Biomed Hub"},{"key":"R77-20260602","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.preteyeres.2004.04.004","article-title":"The role of chemokines and their receptors in ocular disease.","volume":"23","author":"Wallace","year":"2004","journal-title":"Prog Retin Eye Res"},{"key":"R78-20260602","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1146\/annurev.immunol.15.1.675","article-title":"Human chemokines: an update.","volume":"15","author":"Baggiolini","year":"1997","journal-title":"Annu Rev Immunol"},{"key":"R79-20260602","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/j.bbrc.2005.10.062","article-title":"Investigation of CC and CXC chemokine quaternary state mutants.","volume":"338","author":"Jin","year":"2005","journal-title":"Biochem Biophys Res Commun"},{"key":"R80-20260602","doi-asserted-by":"crossref","first-page":"241","DOI":"10.2174\/1381612805666230109213039","article-title":"Interleukin-8: an autocrine inflammatory mediator.","volume":"5","author":"Rahman","year":"1999","journal-title":"Curr Pharm Des"},{"key":"R81-20260602","doi-asserted-by":"crossref","first-page":"2203","DOI":"10.1167\/iovs.06-1358","article-title":"Multiplex bead analysis of vitreous humor of patients with vitreoretinal disorders.","volume":"48","author":"Banerjee","year":"2007","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R82-20260602","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1080\/09273940490518900","article-title":"Interleukin (IL)-6, interleukin (IL)-8 levels and cellular composition of the vitreous humor in proliferative diabetic retinopathy, proliferative vitreoretinopathy, and traumatic proliferative vitreoretinopathy.","volume":"13","author":"Canataroglu","year":"2005","journal-title":"Ocul Immunol Inflamm"},{"key":"R83-20260602","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1136\/bjo.83.11.1296","article-title":"Detection of cytokine mRNA production in infiltrating cells in proliferative vitreoretinopathy using reverse transcription polymerase chain reaction.","volume":"83","author":"El-Ghrably","year":"1999","journal-title":"Br J Ophthalmol"},{"key":"R84-20260602","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/imr.12624","article-title":"Introduction to the interleukin-1 family of cytokines and receptors: drivers of innate inflammation and acquired immunity.","volume":"281","author":"Dinarello","year":"2018","journal-title":"Immunol Rev"},{"key":"R85-20260602","first-page":"4260","article-title":"Interleukin-1-beta changes the expression of metalloproteinases in the vitreous humor and induces membrane formation in eyes containing preexisting retinal holes.","volume":"35","author":"Kosnosky","year":"1994","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R86-20260602","doi-asserted-by":"crossref","first-page":"e1731","DOI":"10.1038\/cddis.2015.73","article-title":"Macrophage- and RIP3-dependent inflammasome activation exacerbates retinal detachment-induced photoreceptor cell death.","volume":"6","author":"Kataoka","year":"2015","journal-title":"Cell Death Dis"},{"key":"R87-20260602","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1136\/bjophthalmol-2014-305263","article-title":"Predicting proliferative vitreoretinopathy: temporal and external validation of models based on genetic and clinical variables.","volume":"99","author":"Rojas","year":"2015","journal-title":"Br J Ophthalmol"},{"key":"R88-20260602","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/S1097-2765(02)00599-3","article-title":"The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-beta.","volume":"10","author":"Martinon","year":"2002","journal-title":"Mol Cell"},{"key":"R89-20260602","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1038\/s41577-019-0165-0","article-title":"The NLRP3 inflammasome: molecular activation and regulation to therapeutics.","volume":"19","author":"Swanson","year":"2019","journal-title":"Nat Rev Immunol"},{"key":"R90-20260602","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.3389\/fimmu.2020.01840","article-title":"Human autoinflammatory diseases mediated by NLRP3-, Pyrin-, NLRP1-, and NLRC4-inflammasome dysregulation updates on diagnosis, treatment, and the respective roles of IL-1 and IL-18.","volume":"11","author":"Alehashemi","year":"2020","journal-title":"Front Immunol"},{"key":"R91-20260602","doi-asserted-by":"crossref","first-page":"2655","DOI":"10.1093\/ndt\/gfp208","article-title":"Interleukin-1 beta regulates proximal tubular cell transforming growth factor beta-1 signalling.","volume":"24","author":"Luo","year":"2009","journal-title":"Nephrol Dial Transplant"},{"key":"R92-20260602","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.freeradbiomed.2016.07.014","article-title":"Angiotensin(1\u20137) attenuated angiotensin II-induced hepatocyte EMT by inhibiting NOX-derived H2O2-activated NLRP3 inflammasome\/IL-1\u03b2\/Smad circuit.","volume":"97","author":"Zhang","year":"2016","journal-title":"Free Radic Biol Med"},{"key":"R93-20260602","doi-asserted-by":"crossref","first-page":"80","DOI":"10.2174\/1874312901206010080","article-title":"The role of the NLRP3 inflammasome in fibrosis.","volume":"6","author":"Artlett","year":"2012","journal-title":"Open Rheumatol J"},{"key":"R94-20260602","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1007\/s00347-020-01293-1","article-title":"Proliferative vitreoretinopathy (PVR) surgery: scar wars: five steps to successful treatment of PVR detachment.","volume":"118","author":"Priglinger","year":"2021","journal-title":"Ophthalmologe"},{"key":"R95-20260602","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.jconrel.2021.03.023","article-title":"Controlled release of triamcinolone from an episcleral micro film delivery system for open-globe eye injuries and proliferative vitreoretinopathy.","volume":"333","author":"Wu","year":"2021","journal-title":"J Control Release"},{"key":"R96-20260602","doi-asserted-by":"crossref","first-page":"22","DOI":"10.18240\/ijo.2023.01.04","article-title":"Intravitreal slow-release dexamethasone alleviates traumatic proliferative vitreoretinopathy by inhibiting persistent inflammation and M\u00fcller cell gliosis in rabbits.","volume":"16","author":"Zhao","year":"2023","journal-title":"Int J Ophthalmol"},{"key":"R97-20260602","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1089\/jop.2021.0072","article-title":"Efficacy of intravitreal dexamethasone after combined phacoemulsification and pars plana vitrectomy for diabetic tractional retinal detachments.","volume":"38","author":"Limon","year":"2022","journal-title":"J Ocul Pharmacol Ther"},{"key":"R98-20260602","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1007\/s00417-011-1730-9","article-title":"The novel use of decorin in prevention of the development of proliferative vitreoretinopathy (PVR).","volume":"249","author":"Nassar","year":"2011","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"R99-20260602","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1080\/15569527.2021.1902343","article-title":"Eupatilin attenuates TGF-\u03b22-induced proliferation and epithelial-mesenchymal transition of retinal pigment epithelial cells.","volume":"40","author":"Cinar","year":"2021","journal-title":"Cutan Ocul Toxicol"},{"key":"R100-20260602","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1167\/iovs.62.4.21","article-title":"Effectively intervening epithelial-mesenchymal transition of retinal pigment epithelial cells with a combination of ROCK and TGF-\u03b2 signaling inhibitors.","volume":"62","author":"Chen","year":"2021","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R101-20260602","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/S0021-5155(02)00698-6","article-title":"Platelet-derived growth factor receptor kinase inhibitor AG1295 and inhibition of experimental proliferative vitreoretinopathy.","volume":"47","author":"Zheng","year":"2003","journal-title":"Jpn J Ophthalmol"},{"key":"R102-20260602","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1095\/biolreprod66.3.745","article-title":"Inhibition of platelet-derived growth factor actions in the embryonic testis influences normal cord development and morphology.","volume":"66","author":"Uzumcu","year":"2002","journal-title":"Biol Reprod"},{"key":"R103-20260602","doi-asserted-by":"crossref","first-page":"100632","DOI":"10.1016\/j.mtbio.2023.100632","article-title":"Non-viral gene therapy using RNA interference with PDGFR-\u03b1 mediated epithelial-mesenchymal transformation for proliferative vitreoretinopathy.","volume":"20","author":"Wang","year":"2023","journal-title":"Mater Today Bio"},{"key":"R104-20260602","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1177\/24741264221135799","article-title":"Intraocular methotrexate for the treatment and prevention of proliferative vitreoretinopathy: a review.","volume":"7","author":"McAllister","year":"2023","journal-title":"J Vitreoretin Dis"},{"key":"R105-20260602","doi-asserted-by":"crossref","first-page":"139","DOI":"10.3928\/23258160-20230220-01","article-title":"Low-dose intravitreal methotrexate for proliferative vitreoretinopathy.","volume":"54","author":"Ullah","year":"2023","journal-title":"Ophthalmic Surg Lasers Imaging Retina"},{"key":"R106-20260602","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1159\/000526091","article-title":"Vitrectomy with silicone oil tamponade and single-dose intravitreal methotrexate for recurrent retinal detachment with proliferative vitreoretinopathy.","volume":"13","author":"Babel","year":"2022","journal-title":"Case Rep Ophthalmol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000044804","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T18:02:57Z","timestamp":1780423377000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000044804"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,26]]},"references-count":106,"journal-issue":{"issue":"39","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000044804","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,26]]},"assertion":[{"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}